Ann: Incannex to Manufacture Psilocybin for Trials & Commercial, page-8

With the current suite of trials, if this comes to fruition as an income stream this elevates IHL immensely. The fact they seem to be pretty far along too, with potential commercial deals already is significant. Not going to be huge income immediately, but it'll be some cashflow.

Not only is this income, but the cost of manufacturing is simply the cost they would be paying others for the products - so its just gravy. They seem to indicate they've got the process sorted too so hopefully no hiccups.